BMBaylie Morgan

Baylie Morgan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Baylie Morgan has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Fraser W. Scott

    Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

    2 shared publications
  • Benjamin Hibbert

    CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

    1 shared publication
  • Christopher Patrick

    Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

    1 shared publication
  • Daniel Serrano

    Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

    1 shared publication
  • Daniel Serrano

    Affiliation Institute for Research in Electronics and Applied Physics, University of Maryland, College Park, Maryland, United States of America

    1 shared publication
  • Dean A. Fergusson

    School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada

    1 shared publication

Latest Publications

  • Open Access

    Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications—The ULTRASITCOM Study

    by Pietro Di Santo, Omar Abdel-Razek, Graeme Prosperi-Porta, Pouya Motazedian, Pascal Thériault-Lauzier, Saad Alhassani, Lee H. Sterling, Simon Parlow, Marie-Eve Mathieu, Richard G. Jung, et al.


  • Open Access

    Dysregulated liver lipid metabolism and innate immunity associated with hepatic steatosis in neonatal BBdp rats and NOD mice

    by D. Serrano, J. A. Crookshank, B. S. Morgan, R. W. Mueller, M.-F. Paré, L. Marandi, P. Poussier, F. W. Scott

    In a previous study we reported that prediabetic rats have a unique gene signature that was apparent even in neonates. Several of the changes we observed, including enhanced expression of pro-inflammatory genes and dysregulated UPR and metabolism genes were first observed in the liver followed by the pancreas. In the present study we investigated further early changes in hepatic innate immunity and metabolism in two models of type 1 diabetes (T1D), the BBdp rat and NOD mouse. There was a striking increase in lipid deposits in liver, particularly in neonatal BBdp rats, with a less striking but significant increase in neonatal NOD mice in association with dysregulated expression of lipid metabolism genes. This was associated with a decreased number of extramedullary hematopoietic clusters as well as CD68+ macrophages in the liver of both models. In addition, PPARɣ and phosphorylated AMPKα protein were decreased in neonatal BBdp rats. BBdp rats displayed decreased expression of antimicrobial genes in neonates and decreased M2 genes at 30 days. This suggests hepatic steatosis could be a common early feature in development of T1D that impacts metabolic homeostasis and tolerogenic phenotype in the prediabetic liver.


  • Changes in insulin, glucagon and ER stress precede immune activation in type 1 diabetes

    by Jennifer A Crookshank, Daniel Serrano, Gen-Sheng Wang, Christopher Patrick, Baylie S Morgan, Marie-France Paré, Fraser W Scott

    It is unknown whether there is a gene signature in pancreas which is associated with type 1 diabetes (T1D). We performed partial pancreatectomies on 30-day preinsulitic, diabetes-prone BioBreeding (BBdp) rats to prospectively identify factors involved in early prediabetes. Microarrays of the biopsies revealed downregulation of endoplasmic reticulum (ER) stress, metabolism and apoptosis. Based on these results, additional investigations compared gene expression in control (BBc) and BBdp rats age ~8, 30 and 60 days using RT-qPCR. Neonates had increased ER stress gene expression in pancreas. This was associated with decreased insulin, cleaved caspase-3 and Ins1 whereas Gcg and Pcsk2 were increased. The increase in ER stress was not sustained at 30 days and decreased by 60 days. In parallel, the liver gene profile showed a similar signature in neonates but with an early decrease of the unfolded protein response (UPR) at 30 days. This suggested that changes in the liver precede those in the pancreas. Tnf and Il1b expression was increased in BBdp pancreas in association with increased caspase-1, cleaved caspase-3 and decreased proinsulin area. Glucagon area was increased in both 30-day and 60-day BBdp rats. Increased colocalization of BIP and proinsulin was observed at 60 days in the pancreas, suggesting insulin-related ER dysfunction. We propose that dysregulated metabolism leads to ER stress in neonatal rats long before insulitis, creating a microenvironment in both pancreas and liver that promotes autoimmunity.